
Sage Therapeutics Investor Relations Material
Latest events

M&A Announcement
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system (CNS) disorders. Its research targets psychiatric, neurological, and neurodevelopmental conditions. The company operates across the drug discovery, clinical development, and commercialization stages, aiming to address unmet medical needs in brain health. Sage Therapeutics Inc is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Sage Therapeutics Inc


Q4 2024
Sage Therapeutics Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Sage Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SAGE
Country
🇺🇸 United States